| 000 | 00998 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516150502.0 | ||
| 264 | 0 | _c20140331 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1744-764X | ||
| 024 | 7 |
_a10.1517/14740338.2013.796362 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStahlmann, Ralf | |
| 245 | 0 | 0 |
_aRisks associated with the therapeutic use of fluoroquinolones. _h[electronic resource] |
| 260 |
_bExpert opinion on drug safety _cJul 2013 |
||
| 300 |
_a497-505 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 |
_aFluoroquinolones _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRisk |
| 700 | 1 | _aLode, Hartmut M | |
| 773 | 0 |
_tExpert opinion on drug safety _gvol. 12 _gno. 4 _gp. 497-505 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14740338.2013.796362 _zAvailable from publisher's website |
| 999 |
_c22731252 _d22731252 |
||